|
Antidepressant Use in
Children, Adolescents, and Adults
The Food and Drug
Administration (FDA) requests a Warning Statement in the labeling
for certain antidepressants to encourage close observation of adult
and pediatric patients treated with these agents for worsening
depression or the emergence of suicidality. The drugs that are the
focus of this new Warning Statement include: Prozac (fluoxetine);
Zoloft (sertraline); Paxil (paroxetine); Luvox (fluvoxamine); Celexa
(citalopram); Lexapro (escitalopram); Wellbutrin (bupropion);
Effexor (venlafaxine); Serzone (nefazodone); and Remeron (mirtazapine).
PDF files, marked with an icon
,
require the free
Adobe
Acrobat Reader.
Back
to Top
Back to Drug Information
Date created: March 22, 2004 |
|